| abstract |
1. The compound having Formula I, its individual enantiomers, individual diastereoisomers, individual hydrates, individual solvates, individual crystalline forms and individual isomers, individual tautomers or their pharmaceutically acceptable salts, where: "" represents a single bond "" or a double bond "" or a triple bond ""; R is H, halogen, -OCalkyl, C1-6alkyl, CN, C (O) R, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle, NRR or hydroxyl; R is the same or independently is halogen, -OCalkyl, C1-6alkyl, CN, C ( O) R, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle, NRR or hydroxyl; R is H, halogen, -OCalkyl, C1-6alkyl, CN, C (O) R, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle, NRR or hydroxyl; R is H, halogen, -OCalkyl, C1-6C, O) R, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle, NRR or hydroxyl; R is the same or independently as halogen, -OCalkyl, C 1-6alkyl, CN, C (O) R, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle, NR R is hydroxy; S, S (= O), S (= O), S (= O) NR, CRR, C = O, C = S or direct bond; R is O, S, NR, CRR or together with R forms a double bond HC = CH or double bond HC = N, or double bond N = CH; R is O, S, NR, CRR or forms together with R double bond HC = CH, or double bond HC = N, or double bond N = CH; R is O, S, NR, CRR or forms together with R a double bond HC = CH or a double bond HC = N, or a double bond N = CH; R is O, S, NR, CRR or forms together with R a double bond HC = CH or a double bond HC = N, or a double bond N = CH; R is H, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle or C1-6 alkyl; R is H, Cycloalkyl, Cycloalkenyl, Caryl, heterocycle or C1-6 C; R is H, Cycloalkyl, Cycloalkenyl, Caryl, hetero |